FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5085311000001109: Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1304291000001114 Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1304301000001113 Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Is a Dobutamine 250mg/20ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has excipient Sodium metabisulfite false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has active ingredient Dobutamine hydrochloride false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Is a Dobutamine 12.5mg/mL concentrate for intravenous infusion 20mL ampule false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dobutamine true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has active ingredient Dobutamine true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has specific active ingredient Dobutamine hydrochloride true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has basis of strength substance Dobutamine true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Is a Dobutamine 250mg/20ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) 5 ampoule Is pack of False Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) 5 ampoule Has AMP True Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Inferred relationship Existential restriction modifier
Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) 10 ampoule 2 x 5 x 20ml ampoules Has AMP True Dobutamine 250mg/20ml concentrate for solution for infusion ampoules (hameln pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start